SIRION Biotech and Denali Therapeutics Join Forces to Develop Gene Therapies for Diseases of the Central Nervous System
SIRION Biotech GmbH, a world leader in viral vector-based gene delivery technologies for gene & cell therapy, announced…
SIRION Biotech GmbH, a world leader in viral vector-based gene delivery technologies for gene & cell therapy, announced…
The viral vector specialist SIRION Biotech GmbH today announces the signing of a preferred partnership agreement with He…
SIRION Biotech GmbH and Vibalogics GmbH, have signed a strategic partnership agreement designed to meet demand from gene…
With the beginning of a new fiscal year SIRION Biotech GmbH, located at the Innovation and Start-Up Center for Biotechno…
Die im Innovations- und Gründerzentrum für Biotechnologie (IZB) Martinsried ansässige SIRION Biotech GmbH meldet zu Jahr…
SIRION Biotech announced today its novel lentivirus portfolio for the most sophisticated in vitro applications. Besides…
SIRION Biotech entwickelt sich weiter in Richtung Kompetenzzentrum für virale Vektoren: alle 3 wichtigen Typen viraler V…
SIRION Biotech has taken a critical step in the company's development towards a viral vector Center of Competence: all t…
Adenovirus vector cloning and production still remain tricky with rather low yields and limited success. The brand new A…